Two Sigma Investments
ACET icon

Two Sigma Investments’s Adicet Bio ACET Stock Holding History

Two Sigma Investments’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$294K Sell
43,106
-101,690
-70% -$761K ﹤0.01% 4087
2025
Q4 		$1.22M Buy
144,796
+91,385
+171% +$1.01M ﹤0.01% 2792
2025
Q3 		$692K Buy
53,411
+21,361
+67% +$252K ﹤0.01% 2816
2025
Q2 		$313K Buy
32,050
+1,114
+4% +$11.7K ﹤0.01% 2776
2025
Q1 		$374K Sell
30,936
-13,024
-30% -$186K ﹤0.01% 2633
2024
Q4 		$677K Sell
43,960
-4
-0% -$75 ﹤0.01% 2390
2024
Q3 		$1.01M Buy
43,964
+4,521
+11% +$101K ﹤0.01% 2115
2024
Q2 		$764K Buy
39,443
+6,845
+21% +$183K ﹤0.01% 2139
2024
Q1 		$1.23M Buy
32,598
+10,053
+45% +$416K ﹤0.01% 1822
2023
Q4 		$682K Buy
22,545
+8,463
+60% +$185K ﹤0.01% 2297
2023
Q3 		$309K Buy
14,082
+4,417
+46% +$156K ﹤0.01% 2481
2023
Q2 		$376K Buy
+9,665
New +$853K ﹤0.01% 2440
2022
Q4 		– Sell
-898
Closed -$204K – 2771
2022
Q3 		$204K Sell
898
-19,683
-96% -$5M ﹤0.01% 2096
2022
Q2 		$4.81M Sell
20,581
-3,969
-16% -$872K 0.02% 793
2022
Q1 		$7.84M Sell
24,550
-19,425
-44% -$4.47M 0.02% 703
2021
Q4 		$12.3M Buy
43,975
+39,137
+809% +$6.72M 0.03% 689
2021
Q3 		$607K Sell
4,838
-3,564
-42% -$442K ﹤0.01% 3067
2021
Q2 		$1.38M Buy
8,402
+1,999
+31% +$407K ﹤0.01% 2195
2021
Q1 		$1.34M Buy
6,403
+4,702
+276% +$1.08M ﹤0.01% 2049
2020
Q4 		$382K Buy
1,701
+1,062
+166% +$218K ﹤0.01% 2686
2020
Q3 		$122K Sell
639
-2,037
-76% -$515K ﹤0.01% 2918
2020
Q2 		$644K Buy
2,676
+67
+3% +$13.2K ﹤0.01% 1833
2020
Q1 		$301K Buy
2,609
+1,329
+104% +$197K ﹤0.01% 2299
2019
Q4 		$214K Buy
+1,280
New +$648K ﹤0.01% 3390

Other funds holding ACET

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Two Sigma Investments's ACET Position: Q1 2026 in Review

Two Sigma Investments reduced its Adicet Bio (ACET) stake by 70% in Q1 2026, selling an estimated $761K and leaving 43,106 shares worth $294K. The position accounts for ﹤0.01% of the portfolio, ranked #4087.

Two Sigma Investments first reported a position in ACET in Q4 2019 and has held it in 24 quarters since. The position peaked at $12.3M in Q4 2021. 49 funds tracked by Wall St. Rank hold ACET as of Q1 2026.

  • Two Sigma Investments held 43,106 shares of Adicet Bio worth $294K as of Q1 2026.
  • Two Sigma Investments sold 101,690 Adicet Bio shares in Q1 2026, an estimated $761K.
  • Adicet Bio made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #4087 holding.
  • Two Sigma Investments first reported a position in Adicet Bio in Q4 2019 and has held it in 24 quarters since.
  • Two Sigma Investments's Adicet Bio position peaked at $12.3M in Q4 2021.
  • 49 funds tracked by Wall St. Rank held Adicet Bio as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.